Skip to the list
English

Lab tools and consumables

The 37 companies in this industry listed on the NYSE and Nasdaq are worth $688 bn combined; the largest are Thermo Fisher Scientific (TMO), Danaher (DHR) and Becton Dickinson (BDX). For each one: what it does, revenue, margin, free cash flow over the last five years and a score from 0 to 10.

Data as of October 2026

Open contest
37 companies value 688 bn revenue 130 bn margin 11.6% free cash flow 20 bn avg. score 2.4
TMO holds 36.5% of the group's value, 1.6x the runner-up
Rank Ticker Company Share Value Revenue Margin FCF 5 years FCF/px Yield What it does · why it is here
1 TMO Thermo Fisher Scientific
United States · score 5.2
 37% 251 bn 46 bn 15.0% 7.3 bn 2.9% 0.3% Instruments, reagents and services for labs and pharma · World's largest supplier of scientific equipment and supplies
2 DHR Danaher
United States · score 5.5
 23% 158 bn 25 bn 15.9% 5.5 bn 3.5% 0.6% Life sciences, diagnostics and biotechnology instruments · Leader in bioprocessing (biologic drug production)
3 BDX Becton Dickinson
United States · score 6.2
 8% 52 bn 22 bn 4.2% 3.2 bn 6.2% 2.3% Syringes, catheters, diagnostics and medication management · World's largest maker of syringes, needles and hospital supplies
4 A Agilent Technologies
United States · score 6.0
 7% 48 bn 7.4 bn 19.5% 1.3 bn 2.6% 0.6% Instruments and reagents for labs and diagnostics · Leader in chromatography and spectrometry for labs
5 WAT Waters Corporation
United States · score 3.8
 6% 43 bn 4.6 bn 3.6% 0.4 bn 0.9% — Liquid chromatography and mass spectrometry · Leader in liquid chromatography for drugmakers
6 MTD Mettler-Toledo
Switzerland/United States · score 6.0
 5% 33 bn 4.1 bn 21.9% 0.9 bn 2.7% — Scales, precision instruments and lab analysis · Dominates precision weighing instruments; very high margins
7 WST West Pharmaceutical Services
United States · score 6.1
 4% 27 bn 3.3 bn 17.0% 0.4 bn 1.6% 0.2% Sealing and delivery components for injectable drugs · Sealing components for injectables; a bottleneck of the biologics industry
8 RVTY REVVITY, INC.
United States · score 5.0
 2% 17 bn 2.9 bn 8.2% 0.6 bn 3.3% 0.2% Technologies and services for life sciences and diagnostics · Massachusetts — revenue of $2.9bn
9 TECH BIO-TECHNE Corp
United States · score 6.1
 2% 11 bn 1.2 bn 9.0% 0.3 bn 2.3% 0.4% Reagents and instruments for research, diagnostics and bioprocessing · Minnesota — revenue of $1.2bn
10 RGEN REPLIGEN CORP
United States · score 5.0
 1% 10 bn 0.8 bn 5.3% 0.1 bn 1.1% — Bioprocessing technologies for biologic drug manufacturing · Massachusetts — revenue of $785m
11 BIO BIO-RAD LABORATORIES, INC.
United States · score 5.5
 1% 9.4 bn 2.6 bn 8.6% 0.3 bn 3.7% — Life science and clinical diagnostics instruments and reagents · California — revenue of $2.6bn
12 BRKR BRUKER CORP
United States · score 1.6
 1% 8.4 bn 3.5 bn -2.0% 0.1 bn 1.1% 0.3% High-performance scientific instruments and diagnostic solutions · Massachusetts — revenue of $3.5bn
13 STVN Stevanato Group S.p.A.
Italy · score 4.6
 1% 5.2 bn 1.3 bn 11.8% 0.0 bn 0.5% 0.3% Vials, syringes and containment systems for pharma, from Italy · Italy — revenue of $1.3bn
14 SHC Sotera Health Co
United States · score 3.6
 1% 5.0 bn 1.2 bn 13.4% 0.1 bn 2.2% — Sterilization and lab testing for medical products and food · Ohio — revenue of $1.2bn
15 MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
United States · score 0.2
 0% 1.8 bn 0.2 bn -37.1% -0.0 bn -2.0% — Materials for messenger RNA, vaccines and diagnostics · California — revenue of $209m
16 ALMR Alamar Biosciences, Inc.
United States · score 0.3
 0% 1.8 bn 0.1 bn -49.5% -0.1 bn -3.8% — High-sensitivity proteomics for protein detection · California — revenue of $100m
17 AZTA Azenta, Inc.
United States · score 2.5
 0% 1.5 bn 0.6 bn -20.0% 0.0 bn 0.6% — Management and exploration of biological and chemical samples · Massachusetts — revenue of $614m
18 CYRX Cryoport, Inc.
United States · score 0.2
 0% 0.9 bn 0.2 bn -20.1% -0.0 bn -2.3% — Temperature-controlled supply chain for life sciences · Tennessee — revenue of $186m
19 MLAB MESA LABORATORIES INC /CO/
United States · score 6.2
 0% 0.7 bn 0.3 bn 1.9% 0.1 bn 7.7% 0.5% Life science tools and regulated quality control · Colorado — revenue of $250m
20 CTKB Cytek Biosciences, Inc.
United States · score 0.8
 0% 0.7 bn 0.2 bn -39.0% -0.0 bn -1.8% — Full-spectrum flow cytometry and cell analysis · California — revenue of $207m
21 OABI OmniAb, Inc.
United States · score 0.0
 0% 0.7 bn 0.0 bn -115.1% -0.0 bn -2.7% — Licensing of antibody discovery platforms · California — revenue of $38m
22 MASS 908 Devices Inc.
United States · score 2.0
 0% 0.5 bn 0.1 bn -57.0% 0.0 bn 0.1% — Point-of-use materials analysis for health, safety and defense · Massachusetts — revenue of $61m
23 TKNO Alpha Teknova, Inc.
United States · score 0.1
 0% 0.4 bn 0.0 bn -38.4% -0.0 bn -2.0% — Critical reagents for discovering and manufacturing therapies · California — revenue of $44m
24 LAB STANDARD BIOTOOLS INC.
United States · score 1.7
 0% 0.3 bn 0.1 bn 100.4% -0.1 bn -32.9% — Instruments, consumables and services for research and clinics · Massachusetts — revenue of $85m
25 NAUT Nautilus Biotechnology, Inc.
United States · score 0.0
 0% 0.3 bn — — -0.1 bn -15.5% — Proteome quantification platform · Washington
26 LFCR LIFECORE BIOMEDICAL, INC. \DE\
United States · score 0.0
 0% 0.2 bn 0.1 bn -29.4% 0.0 bn 1.9% — Contract development and manufacturing of injectable drugs · Minnesota — revenue of $133m
27 KEQU KEWAUNEE SCIENTIFIC CORP /DE/
United States · score 6.1
 0% 0.1 bn 0.3 bn 3.0% 0.0 bn 11.7% 0.4% Laboratory furniture and benches · North Carolina — revenue of $277m
28 QTRX Quanterix Corp
United States · score 0.0
 0% 0.1 bn 0.1 bn -80.2% -0.1 bn -62.4% — Ultrasensitive instruments for biomarkers and spatial biology · Massachusetts — revenue of $153m
29 CDXS CODEXIS, INC.
United States · score 0.0
 0% 0.1 bn 0.1 bn -39.6% -0.0 bn -8.4% — Enzyme technology for drug manufacturing · California — revenue of $78m
30 MXCT MAXCYTE, INC.
United States · score 0.0
 0% 0.1 bn 0.0 bn -114.8% -0.0 bn -17.6% — Cell engineering for cell and gene therapies · Maryland — revenue of $31m
31 SEER Seer, Inc.
United States · score 0.0
 0% 0.1 bn 0.0 bn -478.0% -0.0 bn -39.5% — Nanoparticle proteomics with machine learning · California — revenue of $14m
32 HBIO HARVARD BIOSCIENCE INC
United States · score 0.0
 0% 0.0 bn 0.1 bn -11.9% 0.0 bn -3.0% — Technologies and products for life science research · Massachusetts — revenue of $88m
33 RPID RAPID MICRO BIOSYSTEMS, INC.
United States · score 0.0
 0% 0.0 bn 0.0 bn -145.6% -0.0 bn -104.1% — Automated microbiology testing for pharma · Massachusetts — revenue of $35m
34 DYAI DYADIC INTERNATIONAL INC
United States · score 0.0
 0% 0.0 bn 0.0 bn -200.5% -0.0 bn -53.7% — Proteins and biologics from a fungal platform · Florida — revenue of $4m
35 PLUR Pluri Inc.
Israel · score 0.0
 0% 0.0 bn 0.0 bn -23x -0.0 bn -192.6% — Industrial-scale 3D cell expansion biotech · Israel — revenue of $1m
36 ASTC ASTROTECH Corp
United States · score 0.0
 0% 0.0 bn 0.0 bn -16x -0.0 bn -150.9% — Mass spectrometry for specific applications · Texas
37 ISPC iSpecimen Inc.
United States · score 0.0
 0% 0.0 bn 0.0 bn -25x -0.0 bn -304.5% — Marketplace for human biospecimens for research · Massachusetts

Other industries in the same sector

and 22 industries more
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.

The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.

Have a question or a suggestion, or found a mistake?

Write here: a question about the score, a missing company or industry, a number that looks wrong. Every message is read, and the email is so I can reply.